James A. Bianco, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 40,000 shares at $2.46 ($98K) on 2014-12-19, disclosed to the SEC on 2014-12-19.
Seasonal sale ($98k) by President and CEO — this insider has traded CTIC in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.39 | 4,900 | $12K | 12.0% |
| 2 | $2.40 | 100 | $240 | 0.2% |
| 3 | $2.40 | 4,600 | $11K | 11.3% |
| 4 | $2.41 | 400 | $964 | 1.0% |
| 5 | $2.41 | 9,600 | $23K | 23.7% |
| 6 | $2.42 | 400 |
| $968 |
| 1.0% |
| 7 | $2.45 | 1,200 | $3K | 3.0% |
| 8 | $2.46 | 3,800 | $9K | 9.6% |
| 9 | $2.47 | 8,412 | $21K | 21.3% |
| 10 | $2.48 | 1,588 | $4K | 4.0% |
| 11 | $2.50 | 5,000 | $13K | 12.8% |
| Total | $2.44 avg | 40,000 | $98K | 100% |
| Filing → |
| CTIC | SELL | 2016-04-29 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-30 | $5K | — | Filing → |
| CTIC | SELL | 2016-03-23 | $350K | — | Filing → |